John McKenna

Partner

I am proud to work with some of the most recognized technology companies in the world.

jmckenna@cooley.com

John McKenna practices corporate and securities law, with an emphasis on the representation of publicly traded companies, the formation, financing and general representation of emerging growth companies, and the representation of investors and investment bankers involved with such companies. He has counseled public and private company clients in the full range of corporate and securities matters, including venture financing transactions, public offerings of equity and debt, employee incentive programs, mergers and acquisitions, strategic corporate relationships, SEC reporting and compliance, Sarbanes-Oxley compliance and corporate governance. John is also a market leader in SPAC M&A transactions, counseling both target companies and investors in the de-SPAC process in transactions ranging in value up to $5 billion.

Download full bio 

Experience

  • SeatGeek to Combine With SPAC RedBall Acquisition Corp. 

  • Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion 

  • Rani Therapeutics – $73 Million IPO 

  • Cytek Biosciences – $200 Million IPO 

  • Instructure Holdings – $250 Million IPO 

  • View all

Education

  • Boston University School of Law
    JD, cum laude, 1996

  • California Polytechnic State University, San Luis Obispo
    BS, Business Administration
    1989


Admissions & Credentials

California

Memberships

  • American Bar Association